References
- AcostaEKurlatDHBiscegliaMInduced electric birefringence and viscosity studies in microemulsionsColloids Surfaces A: Physicochem Eng Aspects19961061121
- AngelucciLPetrangeliBCellettiPBioavailability of flufenamic acid in hard and soft gelatin capsulesJ Pharm Sci19766545561263104
- ArmstrongNAJamesKCDrug release from lipid based dosage forms. IIInter J Pharm19806195204
- Avanti® Polar Lipids, LtdHigh-dose fenretinide delivery with novel Lym-X-Sorb™ organized lipid complex [online]2006 Accessed on December 1st, 2006. http://www.avantilipids.com/LXS-DD.asp
- AungstBJIntestinal permeation enhancersJ Pharm Sci2000894294210737905
- BakatselouVOppenheimRCDressmanJBSolubilization and wetting effects of bile salts on the dissolution of steroidsPharm Res19918146191808607
- BarkerSAYapSPYuenKHAn investigation into the structure and bioavailability of alpha-tocopherol dispersions in Gelucire 44/14J Contr Rel20039147788
- BatesTRSequeiraJABioavailability of micronized griseofulvin from corn oil-in-water emulsion, aqueous suspension, and commercial tablet dosage forms in humansJ Pharm Sci19756479371151647
- BatesTRPieniaszekHJJrSequeiraJAGastrointestinal absorption of griseofulvin from corn oil-in-water emulsions: effect of amount of corn oil ingested in manArch Dermatol19771133026843096
- BekermanTGolenserJDombACyclosporin nanoparticulate lipospheres for oral administrationJ Pharm Sci20049312647015067702
- BenetLThe drug efflux-metabolism alliance: biochemical aspectsAdv Drug Deliv Rev200150S3S1111576692
- BergenholtzJRomagnoliAAWagnerNJViscosity, microstructure and interparticle potential of AOT/H2O/n-decane inverse microemulsionsLangmuir199511155970
- BruniGGallettiFSteroidal ethers: urinary excretion of pregnane-diols in man after ingestion of quingestrone in fasting or non-fasting conditionsSteroidologia1970189935520688
- CardielloPGMonhapholTMahanontharitAPharmacokinetics of once-daily saquinavir hard-gelatin capsules and saquinavir soft-gelatin capsules boosted with ritonavir in HIV-1-infected subjectsJAIDS200332375912640194
- CharmanWNRoggeMCBoddyAWEffect of food and a monoglyceride emulsion formulation on danazol bioavailabilityJ Clin Pharmacol19933338168473554
- ConstantinidesPPScalartJPFormulation and physical characterization of water-in-oil microemulsions containing long versus medium chain length glyceridesInt J Pharm19971585768
- CornaireGWoodleyJHermannPImpact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivoInt J Pharm20042781193115158955
- de SmidtPCCampaneroMATroconizIFIntestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibilityInt J Pharm20042701091814726127
- DreweJMeierRVonderscherJEnhancement of the oral absorption of cyclosporin in manBr J Clin Pharmacol1992346041633069
- DunnCJWagstaffAJPerryCMCyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral) in organ transplantationDrugs2001611957201611708766
- el TayarNMarkAEVallatPSolvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulationsJ Med Chem1993363757648254605
- [FDA] Food and Drug AdministrationRitonavir prescribing information [online]2006 Accessed on December 1st, 2006. URL: http://www.fda. gov/cder/foi/label/2003/20659slr030,20945slr013_norvir_lbl.pdf
- FischlerMFrischEPOrtengrenBPlasma concentrations after oral administration of different pharmaceutical preparations of clomethiazoleActa Pharm Suec197310483924773115
- GaoZGChoiHGShinHJPhysicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin AInter J Pharm19981617586
- GershanikTBenitaSSelf-dispersing lipid formulations for improving oral absorption of lipophilic drugsEur J Pharm Biopharm2000501798810840200
- Gonzalez-LlavenJPalma-AguirreJAGarcia-ArreolaRComparative bioavailability evaluation of two cyclosporine oral formulations in healthy Mexican volunteersArch Med Res1999303151910573634
- GursoyRNBenitaSSelf-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugsBiomed Pharmacother2004581738215082340
- HargroveJTMaxsonWSWentzACAbsorption of oral progesterone is influenced by vehicle and particle sizeAm J Obstet Gynecol1989161948512801843
- HolmbergIAknesLBerlinTAbsorption of a pharmacological dose of vitamin D3, from two different lipid vehicles in man: comparison of peanut oil and a medium chain triglycerideBiopharm Drug Dispos199011807152176898
- HoltDWMuellerEAKovarikJMThe pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporineTransplant Proc199426293597940927
- HuggerEDNovakBLBurtonPSA comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitroJ Pharm Sci2002911991200212210046
- HumberstoneAJCharmanWNLipid-based vehicles for the oral delivery of poorly water soluble drugsAdv Drug Deliv Rev19972510328
- HuntJNKnoxMTA relation between the chain length of fatty acids and the slowing of gastric emptyingJ Physiol1968194327365639357
- JuliantoTYuenKHNoorAMImproved bioavailability of vitamin E with a self emulsifying formulationInt J Pharm200020053710845685
- KarpfDMHolmRKristensenHGInfluence of the type of surfactant and the degree of dispersion on the lymphatic transport of halofantrine in conscious ratsPharm Res2004814131815359576
- KhooSMHumberstoneAJPorterCJHEdwardsGACharmanWNFormulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrineInter J Pharm199816715564
- KhossraviMKaoYHMrsnyRJAnalysis methods of polysorbate 20: A new method to assess the stability of polysorbate 20 and established methods that may overlook degraded polysorbate 20Pharm Res20025634912069166
- KlyashchitskyBAOwenAJDrug delivery systems for cyclosporine: achievements and complicationsJ Drug Target199854434589783676
- KovarikJMMuellerEAJohnstonABioequivalence of soft gelatin capsules and oral solution of a new cyclosporine formulationPharmacotherapy199313613178302687
- KovarikJMMuellerEAvan BreeJBReduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulationJ Pharm Sci19948344468207699
- KurowskiMSternfieldTSawyerAPharmacokinetic and tolerability profile of twice daily saquinavir hard gelatin capsules and saquinavir soft gelatin capsules boosted with ritonavir in healthy volunteersHIV Medicine200349410012702129
- LadasSDIsaacsPEMurphyGMComparison of the effects of medium and long chain triglyceride containing liquid meals on gall bladder and small intestinal function in normal manGut1994440511
- LepageGYesairDWRoncoNEffect of an organized lipid matrix on lipid absorption and clinical outcomes in patients with cystic fibrosisJ Pediatr20021411788512183711
- LarsenAJanninVMullertzAPharmaceutical surfacts in biorelevant media: impact on lipolysis and solubility of a poorly soluble model compound: danazol2006Proceedings 5th World Meeting in Pharmaceutics, Biopharmaceutics and Pharmaceutical TechnologyMarch 27–30Geneva, Switzerland
- LawrenceMJReesGDMicroemulsion-based media as novel drug delivery systemsAdv Drug Deliv Rev2000458912111104900
- MacherasPEReppasCIStudies on drug-milk freeze-dried formulations. I: Bioavailability of sulfamethizole and dicumarol formulationsJ Pharm Sci1986a7569262428969
- MacherasPEReppasCIStudies on freeze-dried drug-milk formulations. II: Effect of regenerated fluid volume on nitrofurantoin bioavailabilityJ Pharm Sci1986b751145503559923
- Martin-FacklamMBurhenneJDingRDose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor ELBr J Clin Pharmacol2002535768112047481
- MalingreMMSchellensJHVan TellingenOThe co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patientsBr J Cancer2001851472711720431
- MuellerEAKovarikJMvan BreeJBImproved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulationPharm Res1994a1130148165192
- MuellerEAKovarikJMvan BreeJBInfluence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulationPharm Res1994b1115158140046
- NielsenFSGibaultELjusberg-WahrerHCharacterization of prototype self-nanoemulsifying formulations of lipophilic compoundsJ. Pharm Sci2007968769217279513
- OdebergJMKaufmannPKroonKGLipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporineEur J Pharm Sci2003203758214659481
- PollardSNashanBJohnstonAA pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin AClin Ther20032516546912860490
- PorterCJCharmanWNUptake of drugs into the intestinal lymphatics after oral administrationAdv Drug Deliv Rev1997257189
- PorterCJCharmanWNIn vitro assessment of oral lipid based formulationsAdv Drug Deliv Rev200150S127S14711576699
- PorterCJKaukonenAMBoydBJSusceptibility to lipase-Mediated Digestion Reduces the Oral Bioavailability of Danazol After Administration as a Medium-Chain Lipid-Based Microemulsion FormulationPharm Res2004814051215359575
- PoutonCWFormulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification systemEur J Pharm Sci2006292788716815001
- PostolachePPetrescuODorneanuVCyclosporine bioavailability of two physically different oral formulationsEur Rev Med Pharmacol Sci200261273112776806
- PoutonCWFormulation of self-emulsifying drug delivery systemsAdv Drug Del Rev1997254758
- PoutonCWLipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systemsEur J Pharm Sci200011S93S9811033431
- RegeBDKaoJPPolliJEEffects of nonionic surfactants on membrane transporters in Caco-2 cell monolayersEur J Pharm Sci2002162374612208453
- RegevOEzrahiSAserinAA study of the microstructure of a four-component nonionic microemulsion by cryo-TEM, NMR, SAXS and SANSLangmuir19961266874
- RitschelWAMicroemulsions for improved peptide absorption from the gastrointestinal tractMethods Find Exp Clin Pharmac19961320520
- Roche Laboratories, Inc.Fortovase® prescribing information [online]2004a Accessed on December 1, 2006. URL: http://www.rocheusa. com/products/fortovase/pi.pdf
- RolanPEMercerAJWeatherleyBCExamination of some factors responsible for a food-induced increase in absorption of atova-quoneBr J Clin Pharmacol19943713208148213
- SchmidtLEDalhoffKFood-drug interactionsDrugs200262148150212093316
- SeeballuckFAshfordMBO’DriscollCMThe effects of pluronics block copolymers and cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cellsPharm Res20032010859212880295
- ShonoYNishiharaHMatsudaYModulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranesJ Pharm Sci2004938778514999725
- SinghBNEffects of food on clinical pharmacokineticsClin Pharmacokinet1999372135510511919
- StrickleyRGSolubilizing excipients in oral and injectable formulationsPharm Res2004212013015032302
- VinsonPKSheehanJGMillerWGViewing microemulsions with freeze-fracture transmission electron microscopyJ Phys Chem19919525462550
- WeisMMortensenSARassingMRBioavailability of four oral coenzyme Q10 formulations in healthy volunteersMol Aspects Med199415s273s2807752839
- YamahiraYNoguchiTNoguchiTAbsorption of diazepam from a lipid-containing oral dosage formChem Pharm Bull (Tokyo)19792711908498373
- YapSPYuenKHInfluence of lipolysis and droplet size on tocotrienol absorption from self-emulsifying formulationsInt J Pharm2004281677815288344